HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity is well positioned to compound growth because it is still taking share in a large, expanding HSA market, with total HSA members up 8% y/y, custodial assets up 14% y/y, and total accounts up 4% y/y, while renewals are running well above 90%. Its digital platform is deepening engagement and monetization, as mobile app monthly active users rose to 1.4M+ in July, active marketplace members reached 14,000+, and only about 9% of HSA members are investing despite investing members contributing roughly 4x more. The bullish case is further supported by secular tailwinds from higher-deductible health plans, regulatory expansion, and AI-driven efficiency that has already reduced service costs, creating meaningful margin expansion potential.

HealthEquity is facing a cautious fundamental backdrop because its earnings power is highly sensitive to lower interest rates, weaker investment returns, and slower HSA cash-balance growth if unemployment rises above 5% in 2026. The downside case assumes a recessionary hit to job losses and contributions, only 5% topline growth, and 200 bps of margin contraction in 2027, which suggests limited operating leverage if demand softens. Ongoing risks from competition, alternative payment methods, cyberattacks, and regulatory changes further cloud the outlook, even as valuation at 12.9x 2026 EBITDA already implies slower growth and weaker margins.